Digoxin-BSA bovine
SIGMA/D0565 - lyophilized powder
Synonym: Digoxin-BSA
MDL Number: MFCD01323187
Product Type: Chemical
| biological source | bovine |
| extent of labeling | ~10 mol Digoxin per mol albumin |
| form | lyophilized powder |
| Quality Level | 100 ![]() |
| storage temp. | 2-8°C |
| technique(s) | inhibition assay: suitable |
| UniProt accession no. | P02769 ![]() |
| Application: | Digoxin-BSA bovine is a cardioactive glycoside which can increase intracellular calcium concentration through Na+/K+-ATPase pump inhibition. Digoxin has been used in treatments of heart related disease and also studies of cancer treatments. It has shown the ability to inhibit prostate cancer cell growth, but has also shown a reduction in the efficiency of chemotherapy (reduced drug absorption) by increasing the amount of P-glycoprotein (Pgp). |
| Biochem/physiol Actions: | Antigen-protein conjugate. |
| Physical form: | Lyophilized from 0.06 M Tris |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352202 |

